Literature DB >> 16472681

Quantification of isozyme-specific activation of phospholipase C-beta2 by Rac GTPases and phospholipase C-epsilon by Rho GTPases in an intact cell assay system.

David M Bourdon1, Michele R Wing, Earl B Edwards, John Sondek, T Kendall Harden.   

Abstract

Phospholipase C (PLC) catalyzes the hydrolysis of PtdIns(4,5)P2, which results in both formation of the second messengers Ins(1,4,5)P3 and diacylglycerol and alteration in the membrane association and/or activity of PtdIns(4,5)P2-binding proteins. The existence of 13 different PLC isozymes suggests multiple mechanisms of regulation of inositol lipid signaling, and the recent realization that Rho-family GTPases directly bind and activate certain PLC isozymes has added to this potential diversity of inositol lipid-related signal transduction. With the goal of delineating a less labor-intensive method for quantification of intracellular inositol phosphate production, we have applied a commercially available yttrium silicate RNA binding resin selective for inositol phosphates to develop a high-throughput inositol phosphate scintillation proximity assay (SPA). We highlight the utility of this assay using COS-7 cells robotically transfected in a 96-well format. This method is readily applied to quantify activation of PLC by receptors and G proteins, and we illustrate here the selective activation of PLC-beta2 by Rac but not by Rho GTPases and the selective activation of PLC-epsilon by Rho but not Rac GTPases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472681     DOI: 10.1016/S0076-6879(06)06037-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  20 in total

1.  Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.

Authors:  Hiroshi Maruoka; Matthew O Barrett; Hyojin Ko; Dilip K Tosh; Artem Melman; Lauren E Burianek; Ramachandran Balasubramanian; Barkin Berk; Stefano Costanzi; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

2.  Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity.

Authors:  Ryan T Strachan; Noah Sciaky; Mark R Cronan; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2009-11-20       Impact factor: 4.436

3.  Small molecule inhibitors of phospholipase C from a novel high-throughput screen.

Authors:  Weigang Huang; Matthew Barrett; Nicole Hajicek; Stephanie Hicks; T Kendall Harden; John Sondek; Qisheng Zhang
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

4.  Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.

Authors:  Sara Van Poecke; Matthew O Barrett; T Santhosh Kumar; Davy Sinnaeve; José C Martins; Kenneth A Jacobson; T Kendall Harden; Serge Van Calenbergh
Journal:  Bioorg Med Chem       Date:  2012-02-15       Impact factor: 3.641

5.  VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells.

Authors:  Justin G English; Reid H J Olsen; Katherine Lansu; Michael Patel; Karoline White; Adam S Cockrell; Darshan Singh; Ryan T Strachan; Daniel Wacker; Bryan L Roth
Journal:  Cell       Date:  2019-07-04       Impact factor: 41.582

6.  The mechanism of cell membrane ruffling relies on a phospholipase D2 (PLD2), Grb2 and Rac2 association.

Authors:  Madhu Mahankali; Hong-Juan Peng; Dianne Cox; Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-03-16       Impact factor: 4.315

Review 7.  Cyclin A2: At the crossroads of cell cycle and cell invasion.

Authors:  Abdelhalim Loukil; Caroline T Cheung; Nawal Bendris; Bénédicte Lemmers; Marion Peter; Jean Marie Blanchard
Journal:  World J Biol Chem       Date:  2015-11-26

8.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

9.  Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment.

Authors:  Xi-Ping Huang; Vincent Setola; Prem N Yadav; John A Allen; Sarah C Rogan; Bonnie J Hanson; Chetana Revankar; Matt Robers; Chris Doucette; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

10.  Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling.

Authors:  Ryan T Strachan; Douglas J Sheffler; Belinda Willard; Michael Kinter; Janna G Kiselar; Bryan L Roth
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.